Literature DB >> 12587842

Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus.

Nuntana Kasitanon1, Worawit Louthrenoo, Sucheep Piyasirisilp, Waraporn Sukitawu, Ramjai Wichainun.   

Abstract

Neuropsychiatric (NP) manifestations in patients with systemic lupus erythematosus (SLE) [NPSLE] and prognostic factors were studied in 91 patients. There were 98 NP episodes, of which 78 (79.6%) occurred within the first year of the disease. Twenty-six patients (6.7%) had NPSLE as an initial presentation of the disease. There were seizures in 53 episodes (54.1%), psychosis in 13 (13.3%), acute confusion state in 11 (11.2%), abnormal consciousness in 6 (6.1%), transverse myelitis in 6 (6.1%), peripheral neuropathy in 5 (5.1%), cerebral infarction in 2 (2.0%) and aseptic meningitis in 2 (2.0%). Most forms of NPSLE responded well to high dose corticosteroids. Anti-convulsant therapy could be discontinued within a median duration of 3 months after the SLE activity was under control, and without significant recurrence of seizures. The 5-year and 10-year survival rates of patients with NPSLE were 75.9% and 50.6%, respectively. Patients with NPSLE had significantly more cutaneous vasculitis and less arthritis than those without.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12587842

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  10 in total

Review 1.  Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.

Authors:  George K Bertsias; Dimitrios T Boumpas
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

Review 2.  Lupoid sclerosis.

Authors:  Briele Keiserman; Luiz Fernando Garcias da Silva; Mauro W Keiserman; Carlos Alberto von Mühlen; Henrique Luiz Staub
Journal:  Rheumatol Int       Date:  2009-10-14       Impact factor: 2.631

3.  Neuropsychiatric Symptoms in Lupus.

Authors:  Maria Gulinello; Jing Wen; Chaim Putterman
Journal:  Psychiatr Ann       Date:  2012-09

4.  Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation.

Authors:  Essam A Abda; Zahraa I Selim; Moustafa E M Radwan; Nagham M Mahmoud; Omar M Herdan; Khalid A Mohamad; Sherifa A Hamed
Journal:  Rheumatol Int       Date:  2012-10-12       Impact factor: 2.631

5.  Acute psychosis in systemic lupus erythematosus.

Authors:  Simone Appenzeller; Fernando Cendes; Lilian Tereza Lavras Costallat
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

Review 6.  The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.

Authors:  Maria Gulinello; Chaim Putterman
Journal:  J Biomed Biotechnol       Date:  2011-02-10

Review 7.  Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies.

Authors:  Ziqian Wang; Yanhong Wang; Rongrong Zhu; Xinping Tian; Dong Xu; Qian Wang; Chanyuan Wu; Shangzhu Zhang; Jiuliang Zhao; Yan Zhao; Mengtao Li; Xiaofeng Zeng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 8.  A Systematic Review of Peripheral and Central Nervous System Involvement of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Primary Sjögren's Syndrome, and Associated Immunological Profiles.

Authors:  Anastasia Bougea; Evangelos Anagnostou; Giatas Konstantinos; Paraskevas George; Nikolaos Triantafyllou; Evangelia Kararizou
Journal:  Int J Chronic Dis       Date:  2015-11-25

9.  Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).

Authors:  Yan Li; Amanda R Eskelund; Hua Zhou; David P Budac; Connie Sánchez; Maria Gulinello
Journal:  Int J Mol Sci       Date:  2015-07-03       Impact factor: 5.923

10.  Meningitis as the initial manifestation of systemic lupus erythematosus.

Authors:  Nada Al Mahmeed; Wasim S El Nekidy; Rumman Langah; Ahmad Rakad Nusair
Journal:  IDCases       Date:  2020-07-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.